Skip to main content

8 Result(s)

within P. Biron Remove this filter Cell Biology Remove this filter

and

  1. No Access

    Article

    Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

    This report retrospectively analyzed the outcome of 91 patients aged 60 years or older with refractory/relapsed (R/R) classical Hodgkin's lymphoma (cHL) who underwent autologous stem cell transplantation (ASCT...

    A Stamatoullas, P Brice, M S Gueye, S Mareschal… in Bone Marrow Transplantation (2016)

  2. No Access

    Article

    The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT

    Both auto-SCT and reduced intensity allo-SCT (RIST) are employed in the treatment of relapsed follicular lymphoma (FL). We have analysed the outcome of these two transplant procedures when used as a first tran...

    S P Robinson, C Canals, J J Luang, H Tilly, C Crawley… in Bone Marrow Transplantation (2013)

  3. No Access

    Article

    Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer

    Pegase 03 is a multicenter prospective randomized phase III trial evaluating the impact of first-line high-dose chemotherapy (HDC) with stem cell support on overall survival (OS), disease-free survival (DFS) a...

    P Biron, M Durand, H Roché, T Delozier, C Battista… in Bone Marrow Transplantation (2008)

  4. No Access

    Article

    A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma

    The potential benefit of rituximab as adjuvant to high-dose therapy (HDT) has been investigated in patients under 60 years with poor-risk (age-adjusted international prognostic index at 2–3) CD20+ diffuse larg...

    D Coso, C Sebban, O Boulat, P Biron, J Rey, T Aurran… in Bone Marrow Transplantation (2006)

  5. No Access

    Article

    High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin’s lymphomas: a single center experience on 18 patients

    Between 1985 and 1996, 18 patients with diffuse centrocytic lymphoma (DCL), including nine patients with an established histological and phenotypic diagnosis of mantle cell lymphoma (MCL), received 19 courses ...

    J-Y Blay, C Sebban, C Surbiguet, M Ouachée, I Philip… in Bone Marrow Transplantation (1998)

  6. Article

    Water intake: Influence on development of rat saline hypertension

    Après 7 semaines de surcharge saline administrée par gavage, l'augmentation de tension artérielle systolique de 3 groupes de rats uninephrectomisés soumis à différents régimes d'hydratation s'avéra être en mei...

    Elizabeth Cousineau, P. Biron in Experientia (1972)

    Download PDF (117 KB)

  7. No Access

    Article

    Pressor response to angiotensin I during cardio-pulmonary bypass

    La réponse pressive systémique à des injections intra-artérielles d'angiotensine I et II a été étudiée chez deux chiens avant et après avoir totalement exclu les poumons de la circulation. La réactivité à l'an...

    P. Stanley, P. Biron in Experientia (1969)

  8. No Access

    Article

    Effects of angiotensin on the superior cervical ganglion of the cat

    En quantités inférieures à 10 picogrammes, l'angiotensine inhibe la transmission synaptique du ganglion cervical supérieur du chat, et cet effet est antagonise par la dihydroergotamine. En quantités supérieure...

    J. -C. Panisset, P. Biron, A. Beaulnes in Experientia (1966)